Articles
6940 result(s) for 'sepsis' within Critical Care
Page 23 of 139
-
Citation: Critical Care 2012 16(Suppl 3):P51
-
Role of clinical evaluation committees in sepsis trials: from 'valid cohort' assessment to subgroup analysis
In this issue of Critical Care..., the study from Laterre and colleagues offers suggestions for the role of clinical evaluation committees (CECs) in future sepsis trials. Despite encouraging preliminary results, ...
Citation: Critical Care 2009 13:124 -
Taurine chloramine decreases cell viability and cytokine production in blood and spleen lymphocytes from septic rats submitted to sepsis
Citation: Critical Care 2013 17(Suppl 4):P76 -
Sparing brain damage in severe sepsis: a beginning
Sepsis-associated encephalopathy (SAE) resembles metabolic encephalopathies...
Citation: Critical Care 2010 14:159 -
Sepsis in transit: from clinical to molecular classification
In the previous issue of Critical Care..., Maslove and colleagues studied circulating neutrophil transcriptional expression to discover and validate a molecular subclassification of adult patients with sepsis. Th...
Citation: Critical Care 2012 16:173 -
Performance evaluation and further development of the PCR and microarray-based Prove-it™ Sepsis assay
Citation: Critical Care 2009 13(Suppl 4):P3 -
Gastrin-releasing peptide receptor antagonist induces a protection from lethal sepsis: involvement of toll-like receptor 4 signaling
Citation: Critical Care 2010 14(Suppl 2):P46 -
Activated protein C in sepsis: down but not out, yet
Citation: Critical Care 2006 10:416 -
Angiogenic factors in sepsis: are we ready for the new therapeutic era?
Citation: Critical Care 2014 18:403 -
Insulin and metabolic substrates during human sepsis
Rusavy and colleagues recently endeavoured to dissect out the metabolic effects of insulin in patients with severe sepsis, in the setting of normoglycaemia. Twenty ... demand and catabolism of protein in patients...
Citation: Critical Care 2004 8:227 -
CRYSTMAS study adds to concerns about renal safety and increased mortality in sepsis patients
Citation: Critical Care 2012 16:454 -
Lest we forget the endothelial glycocalyx in sepsis
Sepsis is the third largest cause of death ... are now recognised to underpin the pathophysiology of sepsis. Biomarkers of endothelial activation may therefore assume...
Citation: Critical Care 2012 16:121 -
Deeper understanding of mechanisms contributing to sepsis-induced myocardial dysfunction
The inflammatory response of sepsis results in organ dysfunction, including myocardial dysfunction...
Citation: Critical Care 2014 18:137 -
Corticosteroids for sepsis: registry versus Cochrane systematic review!
A recent report from the PROGRESS registry highlighted that low dose corticosteroids are widely used in patients with sepsis around the world. In this report,...
Citation: Critical Care 2010 14:185 -
Platelets, endothelium and shear join forces to mislead neutrophils in sepsis
Neutrophils are circulating leukocytes with great cytotoxic potential, responsible for the first combat against invading pathogens. Their accumulation in tissues must be highly controlled so that the number of ne...
Citation: Critical Care 2011 15:103 -
Adrenomedullin: a vasodilator to treat sepsis?
Adrenomedullin is a vasodilatory polypeptide with pleiotropic effects secreted by various organs. Adrenomedullin is produced first as a prepropeptide, and then cleaved into mature adrenomedullin and mid-regional ...
Citation: Critical Care 2014 18:152 -
Sepsis-induced lung fibrosis in baboons is reduced by the treatment with a complement inhibitor
Citation: Critical Care 2011 15(Suppl 3):P34 -
Anti-endotoxin immunity in abdominal sepsis patients
Citation: Critical Care 2011 15(Suppl 3):P2 -
Reply to “Hyperoxemia in postsurgical sepsis/septic shock patients is associated with reduced mortality”
Citation: Critical Care 2022 26:177 -
Early fluid therapy with splanchnic sympathetic blockage prevented microcirculation damage, gut bacterial overgrowth, bacterial translocation and mortality in sepsis
Citation: Critical Care 2012 16(Suppl 3):P92 -
PSP/reg and NT-proCNP to predict the occurrence of ICU-acquired sepsis in severe trauma patients: results of a pilot study
Citation: Critical Care 2012 16(Suppl 3):P96 -
Selenium in sepsis – substitution, supplementation or pro-oxidative bolus?
Citation: Critical Care 2014 18:444 -
Long-term risk of sepsis among survivors of acute kidney injury
Many prior studies have shown that, in critically ill patients, acute kidney injury (AKI) commonly occurs in association with sepsis and its presence portends an increased likelihood ... AKI on the long-term risk...
Citation: Critical Care 2014 18:103 -
Effects of statins on mitochondrial respiration and outcome during experimental sepsis
Citation: Critical Care 2012 16(Suppl 3):P24 -
Bedside ultrasound measurement of optic nerve sheath diameter in patients with sepsis: a prospective observational study
Citation: Critical Care 2020 24:235 -
Comment on: Continuous renal replacement therapy with the adsorptive oXiris filter may be associated with the lower 28-day mortality in sepsis: a systematic review and meta-analysis
Citation: Critical Care 2023 27:305 -
Empiric anti-Candida therapy for patients with sepsis in the ICU: how little is too little?
Prior analyses suggest that empiric fluconazole for ICU patients with sepsis is cost-effective. Using updated estimates of...Candida species. Their results are limited by inflated estimates of efficacy, life expe...
Citation: Critical Care 2009 13:180 -
Initial antimicrobial management of sepsis: increased prehospital blood lactate levels for identifying sicker patients who may benefit from prehospital antibiotic therapy initiation
Citation: Critical Care 2021 25:377 -
Appropriate antibiotic dosing in severe sepsis and acute renal failure: factors to consider
Severe sepsis and septic shock cause considerable morbidity and...
Citation: Critical Care 2011 15:175 -
Matrix metalloproteinases and their inhibitors as biomarkers of severity in sepsis
Citation: Critical Care 2010 14:402 -
Cardiovascular effects of β-blockade in a sheep model of severe sepsis
Citation: Critical Care 2011 15(Suppl 3):P36 -
Association of initial intracellular signalling pathway and cytokine level with early mortality in severe sepsis patients
Citation: Critical Care 2014 18(Suppl 2):P46 -
Apolipoprotein M - a new biomarker in sepsis
Sepsis is one of the leading causes of ... and severity are high. Also, treatment of sepsis is highly debated and potential new targets...Critical Care...Kumaraswamy and colleagues have investigated whether plasm...
Citation: Critical Care 2012 16:126 -
Diagnostic and prognostic evaluation of soluble CD14 subtype for sepsis in critically ill patients: a preliminary study
Citation: Critical Care 2014 18(Suppl 2):P50 -
Is nosocomial infection really the major cause of death in sepsis?
No abstract.
Citation: Critical Care 2014 18:540 -
Etomidate for intubation of patients who have sepsis or septic shock - where do we go from here?
Etomidate is an intravenous induction agent that is associated with hemodynamic stability during intubation. The agent is therefore attractive for use in critically ill patients who have a high risk of hemodynami...
Citation: Critical Care 2012 16:189 -
Does low angiopoietin-1 predict adverse outcome in sepsis?
Endothelial injury has emerged as a crucial early event in the pathogenesis of microcirculatory dysfunction, capillary leakage and multiorgan dysfunction syndrome. The endothelial-specific angiopoietin (Ang)/T...
Citation: Critical Care 2010 14:180 -
The key advance in the treatment of sepsis in the last 10 years ... doing less
Although many pharmaceutical and technological advances are heavily touted, they have had relatively little impact on overall outcome improvements in the critically ill. Acting on the increasing recognition th...
Citation: Critical Care 2006 10:122 -
Interleukin-27: a potential new sepsis biomarker exposed through genome-wide transcriptional profiling
Sepsis is a complex clinical condition that is ... ill patients with sterile inflammation from those with sepsis. Such biomarkers may aid the clinician in...Critical Care by a study of critically ill children.
Citation: Critical Care 2012 16:188 -
Etomidate, sepsis, and adrenal function: not as bad as we thought?
The choice of induction agent for endotracheal intubation can have significant downstream effects, especially in critically ill patients. In a retrospective study, Ray and McKeown found that the choice of indu...
Citation: Critical Care 2007 11:145 -
Microvascular endothelial dysfunction: a renewed appreciation of sepsis pathophysiology
Severe sepsis, defined as sepsis associated with acute organ dysfunction, results from ... host response to infection. Coagulopathy in severe sepsis is commonly associated with multiple organ dysfunction, ... pla...
Citation: Critical Care 2001 5(Suppl 2):S1 -
The electrocardiogram for sepsis: how close are we?
In daily clinical practice the diagnosis of sepsis is imprecise and often delayed. In part ... as there is evidence that early events in sepsis may determine outcome. A more objective set of measurements for conf...
Citation: Critical Care 2007 11:144 -
C-reactive protein in community-acquired sepsis: you can teach new tricks to an old dog
Severe sepsis is a major challenge for clinicians caring ... of plasma CRP concentrations in patients with severe sepsis and the interpretation of its patterns may...
Citation: Critical Care 2011 15:186 -
A possible mechanism for immunosuppresion in sepsis
Citation: Critical Care 1999 1:1342 -
Elevated malondialdehyde levels in sepsis - something to 'stress' about?
Oxidative stress has been postulated as a mechanism of organ dysfunction - and thus a potential therapeutic target - in sepsis. Lorente and colleagues report increased serum levels ... -induced lipid peroxidation...
Citation: Critical Care 2014 18:125 -
Hypocholesterolemia in sepsis and critically ill or injured patients
Hypocholesterolemia is an important observation following trauma. In a study of critically ill trauma patients, mean cholesterol levels were significantly lower (119 ± 44 mg/dl) than expected values (201 ± 17 mg/...
Citation: Critical Care 2003 7:413 -
Back to basics in sepsis treatment: critically ill patients need intensive care
Citation: Critical Care 2014 18:405 -
Proinflammatory versus anti-inflammatory response in sepsis patients: looking at the cytokines
Citation: Critical Care 2014 18(Suppl 2):P13 -
N-acetylcysteine in clinical sepsis: a difficult marriage
The high morbidity and mortality of severe sepsis and septic shock fosters a continuous search...N-acetylcysteine shows great promise. Beside proven anti-oxidant, anti-inflammatory and cytoprotective effects, N-a...
Citation: Critical Care 2004 8:229 -
Afelimomab led to a modest mortality benefit in patients with severe sepsis and elevated interleukin-6 levels
Citation: Critical Care 2005 9:E20
Follow
- ISSN: 1364-8535 (electronic)